Granules Q3 results: PAT rises marginally to Rs 126 crore

"We had a steady performance this quarter, which is reflected in our improved EBITDA and PAT margins as compared to the previous quarter," Granules India Chairman & Managing Director Krishna Prasad Chigurupati said.

Its revenue from operations increased to Rs 1,156 crore in the period under review from Rs 1,146 crore in the year-ago period, Granules India said in a regulatory filing. Image Courtesy: Reuters.

Drug firm Granules India on Tuesday said its consolidated profit after tax rose 1 per cent to Rs 126 crore for the third quarter ended December 2023. The company had reported a net profit of Rs 124 crore in the October-December period of last fiscal.

Its revenue from operations increased to Rs 1,156 crore in the period under review from Rs 1,146 crore in the year-ago period, Granules India said in a regulatory filing.

"We had a steady performance this quarter, which is reflected in our improved EBITDA and PAT margins as compared to the previous quarter," Granules India Chairman & Managing Director Krishna Prasad Chigurupati said.

TRENDING NOW

The US formulations business has done well in the third quarter, led by both existing and new products, he added. Shares of the company ended 1.27 per cent down at Rs 411.45 apiece on the BSE.

Catch the latest stock market updates here. For all other news related to business, politics, tech, sports, and auto, visit Zeebiz.com.

TAGS:

Granules India